These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 31200021

  • 1. Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in an uropathogenic Klebsiella pneumoniae isolate.
    Xu Q, Jiang J, Zhu Z, Xu T, Sheng ZK, Ye M, Xu X, Wang M.
    Int J Antimicrob Agents; 2019 Aug; 54(2):223-227. PubMed ID: 31200021
    [Abstract] [Full Text] [Related]

  • 2. RamA upregulates multidrug resistance efflux pumps AcrAB and OqxAB in Klebsiella pneumoniae.
    Xu Q, Sheng Z, Hao M, Jiang J, Ye M, Chen Y, Xu X, Guo Q, Wang M.
    Int J Antimicrob Agents; 2021 Feb; 57(2):106251. PubMed ID: 33259915
    [Abstract] [Full Text] [Related]

  • 3. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital.
    Zhong X, Xu H, Chen D, Zhou H, Hu X, Cheng G.
    PLoS One; 2014 Feb; 9(12):e115185. PubMed ID: 25503276
    [Abstract] [Full Text] [Related]

  • 4. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
    He F, Fu Y, Chen Q, Ruan Z, Hua X, Zhou H, Yu Y.
    PLoS One; 2015 Feb; 10(3):e0119064. PubMed ID: 25734903
    [Abstract] [Full Text] [Related]

  • 5. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae.
    Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, Leflon-Guibout V, Nicolas-Chanoine MH.
    J Antimicrob Chemother; 2015 Jan; 70(1):81-8. PubMed ID: 25193085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. AcrAB-TolC efflux pump overexpression and tet(A) gene mutation increase tigecycline resistance in Klebsiella pneumoniae.
    Xia Z, Zhou J, Gao N, Li G, Liu R, Lu G, Shen J.
    World J Microbiol Biotechnol; 2024 Jun 06; 40(8):233. PubMed ID: 38842631
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tigecycline Susceptibility and Molecular Resistance Mechanisms Among Clinical Klebsiella pneumoniae Strains Isolated During Non-Tigecycline Treatment.
    Li R, Han Y, Zhou Y, Du Z, Wu H, Wang J, Chen Y.
    Microb Drug Resist; 2017 Mar 06; 23(2):139-146. PubMed ID: 27219271
    [Abstract] [Full Text] [Related]

  • 11. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Wang X, Chen H, Zhang Y, Wang Q, Zhao C, Li H, He W, Zhang F, Wang Z, Li S, Wang H.
    Int J Antimicrob Agents; 2015 Jun 06; 45(6):635-40. PubMed ID: 25681067
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae.
    Zheng JX, Lin ZW, Sun X, Lin WH, Chen Z, Wu Y, Qi GB, Deng QW, Qu D, Yu ZJ.
    Emerg Microbes Infect; 2018 Aug 01; 7(1):139. PubMed ID: 30068997
    [Abstract] [Full Text] [Related]

  • 16. Emergence of tigecycline-resistant Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
    Goodarzi R, Arabestani M, Alikhani MY, Keramat F, Asghari B.
    J Infect Dev Ctries; 2021 Nov 30; 15(11):1677-1684. PubMed ID: 34898496
    [Abstract] [Full Text] [Related]

  • 17. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
    Yuhan Y, Ziyun Y, Yongbo Z, Fuqiang L, Qinghua Z.
    Rev Soc Bras Med Trop; 2016 Apr 30; 49(2):165-71. PubMed ID: 27192584
    [Abstract] [Full Text] [Related]

  • 18. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A, Carrasco-Anabalón S, Lima CA, Villagra N, Domínguez M, Bello-Toledo H, González-Rocha G.
    J Glob Antimicrob Resist; 2018 Mar 30; 12():73-76. PubMed ID: 29275225
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial Resistance of Clinical Klebsiella pneumoniae Isolates: Involvement of AcrAB and OqxAB Efflux Pumps.
    Albarri O, AlMatar M, Var I, Köksal F.
    Curr Mol Pharmacol; 2024 Mar 30; 17(1):e310323215266. PubMed ID: 36999690
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.